Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy

Chen, Qichen; Zhang, Yizhou; Li, Xingchen; Huang, Zhen; Zhao, Hong; Cai, Jianqiang

doi:10.7150/jca.65677



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(6):1758-1767. doi:10.7150/jca.65677 This issue Cite

Research Paper

Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy

Qichen Chen^1#, Yizhou Zhang^1#, Xingchen Li^2#, Zhen Huang^1✉, Hong Zhao^1✉, Jianqiang Cai¹

1. Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
2. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
#These authors contributed equally to this work.

Citation:

Chen Q, Zhang Y, Li X, Huang Z, Zhao H, Cai J. Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy. J Cancer 2022; 13(6):1758-1767. doi:10.7150/jca.65677. https://www.jcancer.org/v13p1758.htm

Other styles

Abstract

Background: This study aims to develop a nomogram to predict early recurrence in colorectal liver metastases (CRLM) patients who received neoadjuvant chemotherapy (NAC) followed by hepatectomy.

Methods: The primary cohort included 144 CRLM patients treated in the same ward, and 40 CRLM patients from another ward were allocated to the validation cohort. The minimum p value method was used to find the optimal cut-off point for early recurrence. Predictors of early recurrence were determined by univariate analysis and multivariate logistic regression. Nomogram for early recurrence was constructed and area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis (DCA) were used to evaluate its performance.

Results: The optimal cut-off point for the definition of early recurrence was 11 months. Patients with early recurrence have significantly worse post-recurrence survival (median 23.5 months vs. 35.7 months, P=0.012) and overall survival (median 31.8 months vs. 59.0 months, P<0.001). Preoperative creatinine ≥ 63.5 µmol/L (P=0.035), synchronous liver metastasis (P=0.030), non-R0 resection (P=0.044), postoperative complications (P=0.009) and NAC Cycles ≥ 4 (P=0.003) were independent predictors of early recurrence. A nomogram with favorable discrimination (AUROC of 0.754 in the primary cohort and 0.882 in the validation cohort) and calibration was constructed to predict early recurrence. The DCA results also indicated good clinical applicability.

Conclusions: This is the first study to identify elevated preoperative creatinine as an independent predictor of early recurrence of CRLM treated with hepatectomy after NAC. This study developed a nomogram that particularly incorporated preoperative creatinine to predict early recurrence in CRLM patients receiving NAC to aid clinical decision-making.

Keywords: colorectal liver metastasis, recurrence, neoadjuvant chemotherapy, nomogram

Citation styles

APA

Chen, Q., Zhang, Y., Li, X., Huang, Z., Zhao, H., Cai, J. (2022). Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy. Journal of Cancer, 13(6), 1758-1767. https://doi.org/10.7150/jca.65677.

ACS

Chen, Q.; Zhang, Y.; Li, X.; Huang, Z.; Zhao, H.; Cai, J. Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy. J. Cancer 2022, 13 (6), 1758-1767. DOI: 10.7150/jca.65677.

NLM

CSE

Chen Q, Zhang Y, Li X, Huang Z, Zhao H, Cai J. 2022. Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy. J Cancer. 13(6):1758-1767.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.